London-based dementia care startup Punto Health has raised €2.3 million ($2.7 million) in a Seed funding spherical to speed up product growth and business enlargement throughout the UK and Spain.
The spherical was co-led by Shilling VC and Plus Companions, with participation from Distinctive Ventures, Heartfelt, Fondo Bolsa Social, and ABAC Nest.
“Dementia isn’t only one particular person’s illness. It impacts complete households, and carers typically carry an unlimited invisible burden. We’re constructing know-how that turns a reactive, crisis-driven system into proactive, personalised help that matches into folks’s actual lives,” stated Anna Muñoz-Farré, CEO and co-founder of Punto Well being.
Earlier this 12 months, in June, the corporate won the second version of the NN Social Innovation Startup Award at The Subsequent Net Convention in Amsterdam. It obtained €100k plus a year-long mentorship programme from NN Group and Rubio Influence Ventures. Previous to that, in Might 2024, Punto Health closed a €645k funding spherical. The corporate claims that this Seed spherical builds on a €718.5k ($840k) pre-Seed funding.
Based in 2023 in London by engineers Anna Muñoz-Farré and Jack Eckersley, Punto Well being is a digital well being firm growing AI-powered instruments for early detection and personalised help in dementia and cognitive decline.
The corporate claims to have constructed an working system for dementia care: a multilingual digital platform that connects sufferers, carers, and clinicians throughout three core merchandise. PuntoTest is an AI-powered, speech-based digital check for assessing cognitive impairment in adults. PuntoCare is a companion app for sufferers, carers, and lively seniors. It supplies care plans, cognitive stimulation workout routines, vitamin recommendation, symptom monitoring, bodily exercise steerage, and different wellness help. Its clinician-facing dashboard is named PuntoClinic. It aggregates patient-reported outcomes and biomarker information to help extra personalised, data-driven decision-making, whereas additionally supporting clinicians and researchers.
Punto Well being’s platform is co-designed and clinically validated in partnership with Ace Alzheimer Centre Barcelona. Collectively, they’re constructing a speech-based digital biomarker that may detect modifications in cognitive standing, offering clinicians with an in depth view of illness development throughout a number of cognitive domains.
In response to the corporate, in Spain, PuntoTest has already been examined in a fast cognitive screening programme, alongside Ace Alzheimer Centre and Nutricia, throughout ten pharmacies in Barcelona, and involving greater than 1,500 members aged 50 and above.
The platform can also be being piloted at North London NHS FT, NHS Oxleas FT, Hospital del Mar in Barcelona and Hospital Basic de Granollers, amongst others.
It now helps greater than 200 customers, aged 60 to 90, who’ve accomplished over 30,000 actions, with greater than two-thirds reporting improved confidence in managing their day-to-day routines.
“As a technical founder, I’ve the prospect to construct a workforce that appears extra like the actual world, and to indicate younger ladies that they belong in AI and well being tech. However most of all, I would like households to really feel they’ve a trusted companion at each step, not only a prognosis and a pile of leaflets,” stated Muñoz-Farré.
The corporate is a finalist in VIII Edición de los Premios Discapnet by Fundación ONCE. It has additionally been chosen to be a part of programmes such because the AD Moonshot by Startup Well being, the Alzheimer’s Drug Discovery Basis, and the AI-First Google Accelerator 2025.
